EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische StudieOpen Access · CC BY-NC-ND 4.0

Characteristics of Bleeding Complications in Patients with Severe COVID-19 Requiring Veno-venous Extracorporeal Membrane Oxygenation in Japan

Hayato Taniguchi iD, Takeru Abe, Ichiro Takeuchi, Shinichiro Ohshimo, Nobuaki Shime, Shigeki Kushimoto, Satoru Hashimoto, Shinhiro Takeda, Japan ECMO Network

Thrombosis and Haemostasis · 01.04.2025 · 125 (04) · 308-316

DOI: 10.1055/a-2411-1000 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.04.2025. Verfasst von Hayato Taniguchi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Hauptthemen laut MEDLINE: COVID-19, Extracorporeal Membrane Oxygenation, Hemorrhage. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Complications during veno-venous extracorporeal membrane oxygenation (VV-ECMO) are associated with in-hospital mortality. Asian patients on extracorporeal membrane oxygenation (ECMO) have higher risks of bleeding and in-hospital mortality than Caucasian patients. This study aimed to characterize and identify bleeding complications and their associated factors related to in-hospital mortality in patients with severe coronavirus disease 2019 (COVID-19) requiring VV-ECMO in Japan. In this retrospective observational analysis, the prospective nationwide multicenter registry was used to track real-time information from intensive care units throughout Japan during the COVID-19 pandemic. VV-ECMO patients' registry data between February 1, 2020 and October 31, 2022 were used. This study included 441 patients; 178 (40%) had bleeding complications in the following sites: 20% at the cannulation site, 16% in the gastrointestinal tract, 16% in the ear–nose–throat, 13% at the tracheostomy site, 9% intrathoracic, 6% intracranial, and 5% in the iliopsoas. Anticoagulation was discontinued in >50% of patients with intracranial, iliopsoas, and gastrointestinal tract bleeding. ECMO was discontinued in one-third of patients with intracranial, intramuscular, and iliopsoas hemorrhages. Multivariable logistic regression analysis revealed that only gastrointestinal tract bleeding was associated with in-hospital mortality (odds ratio: 2.49; 95% confidence interval: 1.11–5.60; p = 0.03). Incidence of bleeding complications was 40% in the Japanese population. Gastrointestinal tract bleeding emerged as a significant predictor of adverse outcomes, necessitating further research into preventive strategies and optimized care protocols. These findings can guide the management of VV-ECMO patients with COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Extracorporeal Membrane OxygenationHemorrhageHumansMaleFemaleJapanMiddle AgedRetrospective StudiesAgedHospital MortalityRegistriesRisk FactorsAdultSARS-CoV-2AnticoagulantsSeverity of Illness Index

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Emergency Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Non-profit Organization Japan ECMO Network, Tokyo, Japan.
  • Department of Emergency and Critical Care Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan.
  • Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Non-Profit Organization ICU Collaboration Network (ICON), Tokyo, Japan.
  • Kawaguchi Cardiovascular and Respiratory Hospital, Kawaguchi, Japan.

ORCID-Profile: Hayato Taniguchi

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Taniguchi, H., Abe, T., Takeuchi, I., Ohshimo, S., Shime, N., Kushimoto, S., Hashimoto, S., Takeda, S., & Japan ECMO Network (2025). Characteristics of Bleeding Complications in Patients with Severe COVID-19 Requiring Veno-venous Extracorporeal Membrane Oxygenation in Japan. Thrombosis and Haemostasis, 125(04), 308-316. https://doi.org/10.1055/a-2411-1000

Vancouver

Taniguchi H, Abe T, Takeuchi I, Ohshimo S, Shime N, Kushimoto S, et al. Characteristics of Bleeding Complications in Patients with Severe COVID-19 Requiring Veno-venous Extracorporeal Membrane Oxygenation in Japan. Thrombosis and Haemostasis. 2025;125(04):308-316. doi:10.1055/a-2411-1000

BibTeX
@article{Taniguchi2025,
  author = {Taniguchi, Hayato and Abe, Takeru and Takeuchi, Ichiro and Ohshimo, Shinichiro and Shime, Nobuaki and Kushimoto, Shigeki and Hashimoto, Satoru and Takeda, Shinhiro and Japan ECMO Network, Japan ECMO Network},
  title = {Characteristics of Bleeding Complications in Patients with Severe COVID-19 Requiring Veno-venous Extracorporeal Membrane Oxygenation in Japan},
  journal = {Thrombosis and Haemostasis},
  year = {2025},
  volume = {125},
  number = {04},
  pages = {308--316},
  doi = {10.1055/a-2411-1000}
}
Kostenlos starten →